{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:47:55Z","timestamp":1793886475907,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1756-9966-32-83","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T15:56:31Z","timestamp":1382716591000},"source":"Crossref","is-referenced-by-count":15,"title":["Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition"],"prefix":"10.1186","volume":"32","author":[{"given":"Kazuhiro","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Uda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Makimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Bito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikako","family":"Nishigori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"728_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/14740331003596349","volume":"9","author":"CH Yang","year":"2010","unstructured":"Yang CH, Chuang CK, Hsieh JJ, Chang JW: Targeted therapy and hand-foot skin reaction in advanced renal cell carcinoma. Expert Opin Drug Saf. 2010, 9: 459-470. 10.1517\/14740331003596349.","journal-title":"Expert Opin Drug Saf"},{"key":"728_CR2","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1200\/JCO.2008.21.7828","volume":"28","author":"ME Lacouture","year":"2010","unstructured":"Lacouture ME, Mitchell EP, Piperdi B, Pillai MV, Shearer H, Iannotti N, Xu F, Yassine M: Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol. 2010, 28: 1351-1357. 10.1200\/JCO.2008.21.7828.","journal-title":"J Clin Oncol"},{"key":"728_CR3","first-page":"652","volume":"8","author":"A Degen","year":"2010","unstructured":"Degen A, Alter M, Schenck F, Satzger I, V\u00f6lker B, Kapp A, Gutzmer R: The hand-foot-syndrome associated with medical tumor therapy - classification and management. J Dtsch Dermatol Ges. 2010, 8: 652-661.","journal-title":"J Dtsch Dermatol Ges"},{"key":"728_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1399-0012.2010.01232.x","volume":"24","author":"JM Campistol","year":"2010","unstructured":"Campistol JM, de Fijter JW, Flechner SM, Langone A, Morelon E, Stockfleth E: mTOR inhibitor-associated dermatologic and mucosal problems. Clin Transplant. 2010, 24: 149-156. 10.1111\/j.1399-0012.2010.01232.x.","journal-title":"Clin Transplant"},{"key":"728_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","volume":"58","author":"N Heidary","year":"2008","unstructured":"Heidary N, Naik H, Burgin S: Chemotherapeutic agents and the skin: an update. J Am Acad Dermatol. 2008, 58: 545-570. 10.1016\/j.jaad.2008.01.001.","journal-title":"J Am Acad Dermatol"},{"key":"728_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1447-0594.2011.00729.x","volume":"12","author":"A Nakamura","year":"2012","unstructured":"Nakamura A, Hara K, Yamamoto K, Yasuda H, Moriyama H, Hirai M, Nagata M, Yokono K: Role of the mTOR complex 1 pathway in the in vivo maintenance of the intestinal mucosa by oral intake of amino acids. Geriatr Gerontol Int. 2012, 12: 131-139. 10.1111\/j.1447-0594.2011.00729.x.","journal-title":"Geriatr Gerontol Int"},{"key":"728_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","volume":"356","author":"BD Kahan","year":"2000","unstructured":"Kahan BD: Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group. Lancet. 2000, 356: 194-202. 10.1016\/S0140-6736(00)02480-6.","journal-title":"Lancet"},{"issue":"145","key":"728_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1365-2133.2001.04376.x","volume":"2001","author":"S Reitamo","year":"2001","unstructured":"Reitamo S, Spuls P, Sassolas B, Lahfa M, Claudy A, Griffiths CE, Sirolimus European Psoriasis Study Group: Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol. 2001, 2001 (145): 438-445.","journal-title":"Br J Dermatol"},{"key":"728_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","volume":"79","author":"E Mah\u00e9","year":"2005","unstructured":"Mah\u00e9 E, Morelon E, Lechaton S, Sang KH, Mansouri R, Ducasse MF, Mamzer-Bruneel MF, de Prost Y, Kreis H, Bodemer C: Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy. Transplantation. 2005, 79: 476-482. 10.1097\/01.TP.0000151630.25127.3A.","journal-title":"Transplantation"},{"key":"728_CR10","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell Jr","year":"1997","unstructured":"Darnell JE: STATs and gene regulation. Science. 1997, 277: 1630-1635. 10.1126\/science.277.5332.1630.","journal-title":"Science"},{"key":"728_CR11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002, 3: 651-662.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"728_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-5-14","volume":"5","author":"A Jarnicki","year":"2010","unstructured":"Jarnicki A, Putoczki T, Ernst M: Stat3: linking inflammation to epithelial cancer - more than a \u201cgut\u201d feeling?. Cell Div. 2010, 5: 14-10.1186\/1747-1028-5-14.","journal-title":"Cell Div"},{"key":"728_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/stem.170138","volume":"17","author":"S Akira","year":"1999","unstructured":"Akira S: Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells. 1999, 17: 138-146. 10.1002\/stem.170138.","journal-title":"Stem Cells"},{"key":"728_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1182\/blood-2002-07-2130","volume":"101","author":"Y Aoki","year":"2003","unstructured":"Aoki Y, Feldman GM, Tosato G: Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood. 2003, 101: 1535-1542. 10.1182\/blood-2002-07-2130.","journal-title":"Blood"},{"key":"728_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1073\/pnas.1114232109","volume":"109","author":"N Sen","year":"2012","unstructured":"Sen N, Che X, Rajamani J, Zerboni L, Sung P, Ptacek J, Arvin AM: Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. Proc Natl Acad Sci U S A. 2012, 109: 600-605. 10.1073\/pnas.1114232109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"728_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust J, Sperl B, Hollis A, Mayer TU, Berg T: Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006, 13: 1235-1242. 10.1016\/j.chembiol.2006.09.018.","journal-title":"Chem Biol"},{"key":"728_CR17","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1073\/pnas.0409894102","volume":"102","author":"H Song","year":"2005","unstructured":"Song H, Wang R, Wang S, Lin J: A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A. 2005, 102: 4700-4705. 10.1073\/pnas.0409894102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"728_CR18","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1158\/1535-7163.MCT-08-0279","volume":"7","author":"J Sayyah","year":"2008","unstructured":"Sayyah J, Magis A, Ostrov DA, Allan RW, Braylan RC, Sayeski PP: Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. Mol Cancer Ther. 2008, 7: 2308-2318. 10.1158\/1535-7163.MCT-08-0279.","journal-title":"Mol Cancer Ther"},{"key":"728_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol. 1988, 106: 761-771. 10.1083\/jcb.106.3.761.","journal-title":"J Cell Biol"},{"key":"728_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2008.12.033","volume":"278","author":"K Takara","year":"2009","unstructured":"Takara K, Kitada N, Yoshikawa E, Yamamoto K, Horibe S, Sakaeda T, Nishiguchi K, Ohnishi N, Yokoyama T: Molecular changes to HeLa cells on continuous exposure to SN-38, an active metabolite of irinotecan hydrochloride. Cancer Lett. 2009, 278: 88-96. 10.1016\/j.canlet.2008.12.033.","journal-title":"Cancer Lett"},{"key":"728_CR21","first-page":"603","volume":"5","author":"K Takara","year":"2012","unstructured":"Takara K, Matsubara M, Yamamoto K, Minegaki T, Takegami S, Takahashi M, Yokoyama T, Okumura K: Differential effects of calcium antagonists on ABCG2\/BCRP-mediated drug resistance and transport in SN-38-resistant HeLa cells. Mol Med Report. 2012, 5: 603-609.","journal-title":"Mol Med Report"},{"key":"728_CR22","doi-asserted-by":"publisher","first-page":"e30697","DOI":"10.1371\/journal.pone.0030697","volume":"7","author":"K Takara","year":"2012","unstructured":"Takara K, Yamamoto K, Matsubara M, Minegaki T, Takahashi M, Yokoyama T, Okumura K: Effects of \u03b1-Adrenoceptor Antagonists on ABCG2\/BCRP-Mediated Resistance and Transport. PLoS One. 2012, 7: e30697-10.1371\/journal.pone.0030697.","journal-title":"PLoS One"},{"key":"728_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","volume":"98","author":"JF Bromberg","year":"1999","unstructured":"Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE: Stat3 as an Oncogene. Cell. 1999, 98: 295-303. 10.1016\/S0092-8674(00)81959-5.","journal-title":"Cell"},{"key":"728_CR24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/nar\/25.11.2062","volume":"25","author":"Z Wen","year":"1997","unstructured":"Wen Z, Darnell JE: Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 1997, 25: 2062-2067. 10.1093\/nar\/25.11.2062.","journal-title":"Nucleic Acids Res"},{"key":"728_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1152\/ajpgi.00344.2005","volume":"290","author":"M Takaoka","year":"2006","unstructured":"Takaoka M, Smith CE, Mashiba MK, Okawa T, Andl CD, El-Deiry WS, Nakagawa H: EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I. Am J Physiol Gastrointest Liver Physiol. 2006, 290: 404-416. 10.1152\/ajpgi.00344.2005.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"728_CR26","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.cellsig.2008.06.010","volume":"20","author":"C Cao","year":"2008","unstructured":"Cao C, Lu S, Jiang Q, Wang WJ, Song X, Kivlin R, Wallin B, Bagdasarian A, Tamakloe T, Chu WM, Marshall J, Kouttab N, Xu A, Wan Y: EGFR activation confers protections against UV-induced apoptosis in cultured mouse skin dendritic cells. Cell Signal. 2008, 20: 1830-1838. 10.1016\/j.cellsig.2008.06.010.","journal-title":"Cell Signal"},{"key":"728_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12011-012-9387-8","volume":"148","author":"D Liang","year":"2012","unstructured":"Liang D, Yang M, Guo B, Cao J, Yang L, Guo X, Li Y, Gao Z: Zinc inhibits H(2)O(2)-induced MC3T3-E1 cells apoptosis via MAPK and PI3K\/AKT pathways. Biol Trace Elem Res. 2012, 148: 420-429. 10.1007\/s12011-012-9387-8.","journal-title":"Biol Trace Elem Res"},{"key":"728_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jaad.2006.09.005","volume":"56","author":"JC Hu","year":"2007","unstructured":"Hu JC, Sadeghi P, Pinter-Brown LC, Yashar S, Chiu MW: Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management. J Am Acad Dermatol. 2007, 56: 317-326. 10.1016\/j.jaad.2006.09.005.","journal-title":"J Am Acad Dermatol"},{"key":"728_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1529-8019.2011.01435.x","volume":"24","author":"B McLellan","year":"2012","unstructured":"McLellan B, Kerr H: Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib. Dermatol Ther. 2012, 24: 396-400.","journal-title":"Dermatol Ther"},{"key":"728_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-010-9249-4","volume":"5","author":"S Ogasawara","year":"2011","unstructured":"Ogasawara S, Kanai F, Obi S, Sato S, Yamaguchi T, Azemoto R, Mizumoto H, Koushima Y, Morimoto N, Hirata N, Toriyabe T, Shinozaki Y, Ooka Y, Mikata R, Chiba T, Okabe S, Imazeki F, Yoshikawa M, Yokosuka O: Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatol Int. 2011, 5: 850-856. 10.1007\/s12072-010-9249-4.","journal-title":"Hepatol Int"},{"key":"728_CR31","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1158\/0008-5472.CAN-04-0214","volume":"64","author":"MR Quadros","year":"2004","unstructured":"Quadros MR, Peruzzi F, Kari C, Rodeck U: Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Cancer Res. 2004, 64: 3934-3939. 10.1158\/0008-5472.CAN-04-0214.","journal-title":"Cancer Res"},{"key":"728_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molmed.2006.11.001","volume":"13","author":"B Barr\u00e9","year":"2007","unstructured":"Barr\u00e9 B, Vigneron A, Perkins N, Roninson IB, Gamelin E, Coqueret O: The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med. 2007, 13: 4-11. 10.1016\/j.molmed.2006.11.001.","journal-title":"Trends Mol Med"},{"key":"728_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci. 2009, 1171: 59-76. 10.1111\/j.1749-6632.2009.04911.x.","journal-title":"Ann N Y Acad Sci"},{"key":"728_CR34","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1038\/sj.onc.1210567","volume":"26","author":"C Lufei","year":"2007","unstructured":"Lufei C, Koh TH, Uchida T, Cao X: Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene. 2007, 26: 7656-7664. 10.1038\/sj.onc.1210567.","journal-title":"Oncogene"},{"key":"728_CR35","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/ATVBAHA.112.245381","volume":"32","author":"W Martinet","year":"2012","unstructured":"Martinet W, Verheye S, De Meyer I, Timmermans JP, Schrijvers DM, Van Brussel I, Bult H, De Meyer GR: Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid. Arterioscler Thromb Vasc Biol. 2012, 32: 1228-1235. 10.1161\/ATVBAHA.112.245381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"728_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1042\/BST20110609","volume":"40","author":"E Aksamitiene","year":"2012","unstructured":"Aksamitiene E, Kiyatkin A, Kholodenko BN: Cross-talk between mitogenic Ras\/MAPK and survival PI3K\/Akt pathways: a fine balance. Biochem Soc Trans. 2012, 40: 139-146. 10.1042\/BST20110609.","journal-title":"Biochem Soc Trans"},{"key":"728_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","volume":"134","author":"P Coppo","year":"2006","unstructured":"Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, Lacout C, Guilhot F, Vainchenker W, Turhan AG: BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol. 2006, 134: 171-179. 10.1111\/j.1365-2141.2006.06161.x.","journal-title":"Br J Haematol"},{"key":"728_CR38","doi-asserted-by":"publisher","first-page":"52154","DOI":"10.1074\/jbc.M307299200","volume":"278","author":"RK Lo","year":"2003","unstructured":"Lo RK, Cheung H, Wong YH: Constitutively active Galpha16 stimulates STAT3 via a c-Src\/JAK- and ERK-dependent mechanism. J Biol Chem. 2003, 278: 52154-52165. 10.1074\/jbc.M307299200.","journal-title":"J Biol Chem"},{"key":"728_CR39","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.1128\/MCB.19.11.7519","volume":"19","author":"J Turkson","year":"1999","unstructured":"Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R: Requirement for Ras\/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol. 1999, 19: 7519-7528.","journal-title":"Mol Cell Biol"},{"key":"728_CR40","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1074\/jbc.M112.418335","volume":"288","author":"F Yang","year":"2013","unstructured":"Yang F, Zhang W, Li D, Zhan Q: Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR\/STAT3 protein pathway. J Biol Chem. 2013, 288: 6552-6560. 10.1074\/jbc.M112.418335.","journal-title":"J Biol Chem"},{"key":"728_CR41","doi-asserted-by":"publisher","first-page":"31055","DOI":"10.1074\/jbc.274.43.31055","volume":"274","author":"CP Lim","year":"1999","unstructured":"Lim CP, Cao X: Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem. 1999, 274: 31055-31061. 10.1074\/jbc.274.43.31055.","journal-title":"J Biol Chem"},{"key":"728_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1365-2133.2010.10038.x","volume":"164","author":"PH Lu","year":"2011","unstructured":"Lu PH, Kuo TC, Chang KC, Chang CH, Chu CY: Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway. Br J Dermatol. 2011, 164: 38-46. 10.1111\/j.1365-2133.2010.10038.x.","journal-title":"Br J Dermatol"},{"key":"728_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.0906-6705.2006.00407.x","volume":"15","author":"N Sumita","year":"2006","unstructured":"Sumita N, Bito T, Nakajima K, Nishigori C: Stat3 activation is required for cell proliferation and tumorigenesis but not for cell viability in cutaneous squamous cell carcinoma cell lines. Exp Dermatol. 2006, 15: 291-299. 10.1111\/j.0906-6705.2006.00407.x.","journal-title":"Exp Dermatol"},{"key":"728_CR44","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1345\/aph.1L330","volume":"42","author":"F Pea","year":"2008","unstructured":"Pea F, Baccarani U, Tavio M, Cojutti P, Adani GL, Londero A, Baraldo M, Franceschi L, Furlanut M, Viale P: Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient. Ann Pharmacother. 2008, 42: 1711-1716. 10.1345\/aph.1L330.","journal-title":"Ann Pharmacother"},{"key":"728_CR45","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1023\/A:1011940108365","volume":"15","author":"A Crowe","year":"1998","unstructured":"Crowe A, Lemaire M: In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm Res. 1998, 15: 1666-1672. 10.1023\/A:1011940108365.","journal-title":"Pharm Res"},{"key":"728_CR46","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/0008-5472.CAN-08-4323","volume":"69","author":"H Xin","year":"2009","unstructured":"Xin H, Zhang C, Herrmann A, Du Y, Figlin R, Yu H: Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 2009, 69: 2506-2513. 10.1158\/0008-5472.CAN-08-4323.","journal-title":"Cancer Res"},{"key":"728_CR47","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1200\/JCO.2006.09.8897","volume":"25","author":"N Ito","year":"2007","unstructured":"Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, Kanayama H, Nose Y, Kinukawa N, Nakamura T, Jinnai N, Seki T, Takamatsu M, Masui Y, Naito S, Ogawa O: STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. J Clin Oncol. 2007, 25: 2785-2791. 10.1200\/JCO.2006.09.8897.","journal-title":"J Clin Oncol"},{"key":"728_CR48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10549-008-0020-7","volume":"114","author":"ME Lacouture","year":"2009","unstructured":"Lacouture ME, Laabs SM, Koehler M, Sweetman RW, Preston AJ, Di Leo A, Gomez HL, Salazar VM, Byrne JA, Koch KM, Blackwell KL: Analysis of dermatologic events in patients with cancer treated with lapatinib. Breast Cancer Res Treat. 2009, 114: 485-493. 10.1007\/s10549-008-0020-7.","journal-title":"Breast Cancer Res Treat"},{"key":"728_CR49","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1158\/0008-5472.CAN-04-4359","volume":"65","author":"S Sano","year":"2005","unstructured":"Sano S, Chan KS, Kira M, Kataoka K, Takagi S, Tarutani M, Itami S, Kiguchi K, Yokoi M, Sugasawa K, Mori T, Hanaoka F, Takeda J, DiGiovanni J: Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res. 2005, 65: 5720-5729. 10.1158\/0008-5472.CAN-04-4359.","journal-title":"Cancer Res"},{"key":"728_CR50","first-page":"RE2","volume":"2003","author":"AM Bode","year":"2003","unstructured":"Bode AM, Dong Z: Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci STKE. 2003, 2003: RE2-","journal-title":"Sci STKE"},{"key":"728_CR51","doi-asserted-by":"publisher","first-page":"28897","DOI":"10.1074\/jbc.M804144200","volume":"283","author":"C Cao","year":"2008","unstructured":"Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, Tamakloe T, Chu WM, Guan KL, Wan Y: AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol Chem. 2008, 283: 28897-28908. 10.1074\/jbc.M804144200.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-32-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-32-83\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-32-83.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T08:40:28Z","timestamp":1548232828000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-32-83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-32-83","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]},"article-number":"83"}}